A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer (Q36821702)
Jump to navigation
Jump to search
scientific article published on 12 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer |
scientific article published on 12 April 2013 |
Statements
1 reference
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer (English)
1 reference
Jose Baselga
1 reference
Shanu Modi
1 reference
Joyce O'Shaughnessy
1 reference
Nancy U Lin
1 reference
Cristina Saura
1 reference
Charles Henderson
1 reference
Reshma Mahtani
1 reference
Jill Goddard
1 reference
Eduardo Rodenas
1 reference
Clifford Hudis
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference